Biomarkers of exposure to new and emerging tobacco delivery products

Suzaynn F. Schick, Benjamin C. Blount, Peyton Jacob, Najat A. Saliba, John T. Bernert, Ahmad El Hellani, Peter Jatlow, R. Steven Pappas, Lanqing Wang, Jonathan Foulds, Arunava Ghosh, Stephen S. Hecht, John C. Gomez, Jessica R. Martin, Clementina Mesaros, Sanjay Srivastava, Gideon St. Helen, Robert Tarran, Pawel K. Lorkiewicz, Ian A. BlairHeather L. Kimmel, Claire M. Doerschuk, Neal L. Benowitz, Aruni Bhatnagar

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Accurate and reliable measurements of exposure to tobacco products are essential for identifying and confirming patterns of tobacco product use and for assessing their potential biological effects in both human populations and experimental systems. Due to the introduction of new tobaccoderived products and the development of novel ways to modify and use conventional tobacco products, precise and specific assessments of exposure to tobacco are now more important than ever. Biomarkers that were developed and validated to measure exposure to cigarettes are being evaluated to assess their use for measuring exposure to these new products. Here, we review current methods for measuring exposure to new and emerging tobacco products, such as electronic cigarettes, little cigars, water pipes, and cigarillos. Rigorously validated biomarkers specific to these new products have not yet been identified. Here, we discuss the strengths and limitations of current approaches, including whether they provide reliable exposure estimates for new and emerging products. We provide specific guidance for choosing practical and economical biomarkers for different study designs and experimental conditions. Our goal is to help both new and experienced investigators measure exposure to tobacco products accurately and avoid common experimental errors. With the identification of the capacity gaps in biomarker research on new and emerging tobacco products, we hope to provide researchers, policymakers, and funding agencies with a clear action plan for conducting and promoting research on the patterns of use and health effects of these products.

Original languageEnglish (US)
Pages (from-to)L425-L452
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume313
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Tobacco Products
Biomarkers
Research Personnel
Tobacco Use
Research
Tobacco
Research Design
Water
Health
Population

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Schick, S. F., Blount, B. C., Jacob, P., Saliba, N. A., Bernert, J. T., El Hellani, A., ... Bhatnagar, A. (2017). Biomarkers of exposure to new and emerging tobacco delivery products. American Journal of Physiology - Lung Cellular and Molecular Physiology, 313(3), L425-L452. https://doi.org/10.1152/ajplung.00343.2016
Schick, Suzaynn F. ; Blount, Benjamin C. ; Jacob, Peyton ; Saliba, Najat A. ; Bernert, John T. ; El Hellani, Ahmad ; Jatlow, Peter ; Pappas, R. Steven ; Wang, Lanqing ; Foulds, Jonathan ; Ghosh, Arunava ; Hecht, Stephen S. ; Gomez, John C. ; Martin, Jessica R. ; Mesaros, Clementina ; Srivastava, Sanjay ; St. Helen, Gideon ; Tarran, Robert ; Lorkiewicz, Pawel K. ; Blair, Ian A. ; Kimmel, Heather L. ; Doerschuk, Claire M. ; Benowitz, Neal L. ; Bhatnagar, Aruni. / Biomarkers of exposure to new and emerging tobacco delivery products. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2017 ; Vol. 313, No. 3. pp. L425-L452.
@article{19cd2d6d054e40d6bb36e3037ff151ab,
title = "Biomarkers of exposure to new and emerging tobacco delivery products",
abstract = "Accurate and reliable measurements of exposure to tobacco products are essential for identifying and confirming patterns of tobacco product use and for assessing their potential biological effects in both human populations and experimental systems. Due to the introduction of new tobaccoderived products and the development of novel ways to modify and use conventional tobacco products, precise and specific assessments of exposure to tobacco are now more important than ever. Biomarkers that were developed and validated to measure exposure to cigarettes are being evaluated to assess their use for measuring exposure to these new products. Here, we review current methods for measuring exposure to new and emerging tobacco products, such as electronic cigarettes, little cigars, water pipes, and cigarillos. Rigorously validated biomarkers specific to these new products have not yet been identified. Here, we discuss the strengths and limitations of current approaches, including whether they provide reliable exposure estimates for new and emerging products. We provide specific guidance for choosing practical and economical biomarkers for different study designs and experimental conditions. Our goal is to help both new and experienced investigators measure exposure to tobacco products accurately and avoid common experimental errors. With the identification of the capacity gaps in biomarker research on new and emerging tobacco products, we hope to provide researchers, policymakers, and funding agencies with a clear action plan for conducting and promoting research on the patterns of use and health effects of these products.",
author = "Schick, {Suzaynn F.} and Blount, {Benjamin C.} and Peyton Jacob and Saliba, {Najat A.} and Bernert, {John T.} and {El Hellani}, Ahmad and Peter Jatlow and Pappas, {R. Steven} and Lanqing Wang and Jonathan Foulds and Arunava Ghosh and Hecht, {Stephen S.} and Gomez, {John C.} and Martin, {Jessica R.} and Clementina Mesaros and Sanjay Srivastava and {St. Helen}, Gideon and Robert Tarran and Lorkiewicz, {Pawel K.} and Blair, {Ian A.} and Kimmel, {Heather L.} and Doerschuk, {Claire M.} and Benowitz, {Neal L.} and Aruni Bhatnagar",
year = "2017",
month = "9",
day = "1",
doi = "10.1152/ajplung.00343.2016",
language = "English (US)",
volume = "313",
pages = "L425--L452",
journal = "American Journal of Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "3",

}

Schick, SF, Blount, BC, Jacob, P, Saliba, NA, Bernert, JT, El Hellani, A, Jatlow, P, Pappas, RS, Wang, L, Foulds, J, Ghosh, A, Hecht, SS, Gomez, JC, Martin, JR, Mesaros, C, Srivastava, S, St. Helen, G, Tarran, R, Lorkiewicz, PK, Blair, IA, Kimmel, HL, Doerschuk, CM, Benowitz, NL & Bhatnagar, A 2017, 'Biomarkers of exposure to new and emerging tobacco delivery products', American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 313, no. 3, pp. L425-L452. https://doi.org/10.1152/ajplung.00343.2016

Biomarkers of exposure to new and emerging tobacco delivery products. / Schick, Suzaynn F.; Blount, Benjamin C.; Jacob, Peyton; Saliba, Najat A.; Bernert, John T.; El Hellani, Ahmad; Jatlow, Peter; Pappas, R. Steven; Wang, Lanqing; Foulds, Jonathan; Ghosh, Arunava; Hecht, Stephen S.; Gomez, John C.; Martin, Jessica R.; Mesaros, Clementina; Srivastava, Sanjay; St. Helen, Gideon; Tarran, Robert; Lorkiewicz, Pawel K.; Blair, Ian A.; Kimmel, Heather L.; Doerschuk, Claire M.; Benowitz, Neal L.; Bhatnagar, Aruni.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 313, No. 3, 01.09.2017, p. L425-L452.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biomarkers of exposure to new and emerging tobacco delivery products

AU - Schick, Suzaynn F.

AU - Blount, Benjamin C.

AU - Jacob, Peyton

AU - Saliba, Najat A.

AU - Bernert, John T.

AU - El Hellani, Ahmad

AU - Jatlow, Peter

AU - Pappas, R. Steven

AU - Wang, Lanqing

AU - Foulds, Jonathan

AU - Ghosh, Arunava

AU - Hecht, Stephen S.

AU - Gomez, John C.

AU - Martin, Jessica R.

AU - Mesaros, Clementina

AU - Srivastava, Sanjay

AU - St. Helen, Gideon

AU - Tarran, Robert

AU - Lorkiewicz, Pawel K.

AU - Blair, Ian A.

AU - Kimmel, Heather L.

AU - Doerschuk, Claire M.

AU - Benowitz, Neal L.

AU - Bhatnagar, Aruni

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Accurate and reliable measurements of exposure to tobacco products are essential for identifying and confirming patterns of tobacco product use and for assessing their potential biological effects in both human populations and experimental systems. Due to the introduction of new tobaccoderived products and the development of novel ways to modify and use conventional tobacco products, precise and specific assessments of exposure to tobacco are now more important than ever. Biomarkers that were developed and validated to measure exposure to cigarettes are being evaluated to assess their use for measuring exposure to these new products. Here, we review current methods for measuring exposure to new and emerging tobacco products, such as electronic cigarettes, little cigars, water pipes, and cigarillos. Rigorously validated biomarkers specific to these new products have not yet been identified. Here, we discuss the strengths and limitations of current approaches, including whether they provide reliable exposure estimates for new and emerging products. We provide specific guidance for choosing practical and economical biomarkers for different study designs and experimental conditions. Our goal is to help both new and experienced investigators measure exposure to tobacco products accurately and avoid common experimental errors. With the identification of the capacity gaps in biomarker research on new and emerging tobacco products, we hope to provide researchers, policymakers, and funding agencies with a clear action plan for conducting and promoting research on the patterns of use and health effects of these products.

AB - Accurate and reliable measurements of exposure to tobacco products are essential for identifying and confirming patterns of tobacco product use and for assessing their potential biological effects in both human populations and experimental systems. Due to the introduction of new tobaccoderived products and the development of novel ways to modify and use conventional tobacco products, precise and specific assessments of exposure to tobacco are now more important than ever. Biomarkers that were developed and validated to measure exposure to cigarettes are being evaluated to assess their use for measuring exposure to these new products. Here, we review current methods for measuring exposure to new and emerging tobacco products, such as electronic cigarettes, little cigars, water pipes, and cigarillos. Rigorously validated biomarkers specific to these new products have not yet been identified. Here, we discuss the strengths and limitations of current approaches, including whether they provide reliable exposure estimates for new and emerging products. We provide specific guidance for choosing practical and economical biomarkers for different study designs and experimental conditions. Our goal is to help both new and experienced investigators measure exposure to tobacco products accurately and avoid common experimental errors. With the identification of the capacity gaps in biomarker research on new and emerging tobacco products, we hope to provide researchers, policymakers, and funding agencies with a clear action plan for conducting and promoting research on the patterns of use and health effects of these products.

UR - http://www.scopus.com/inward/record.url?scp=85028707767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028707767&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00343.2016

DO - 10.1152/ajplung.00343.2016

M3 - Article

C2 - 28522563

AN - SCOPUS:85028707767

VL - 313

SP - L425-L452

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1040-0605

IS - 3

ER -